---  
layout: startup_page  
title: "Numab Therapeutics"  
id: "numab.com"  
permalink: "/numabtherapeuticsnumab.com01102025/"  
website: "https://www.numab.com/"  
funding_round: "Series C"  
funding_amount: "$55M"  
investors: "Cormorant Asset Management, Forbion, HBM Healthcare Investment, Novo Holdings, BVF Partners LP, Octagon Capital Advisors LP, RTW Investments, BlackRock"  
about: "Numab Therapeutics is a clinical-stage biotech company developing multi-specific antibody-based immunotherapies for inflammation and cancer. They utilize proprietary technology platforms, Î»-CapTM and MATCHTM, to overcome drug discovery challenges and build a pipeline of novel medicines. Their lead asset, NM32, is currently in Phase 1 trials."  
markets: "Biotech, Oncology, Immunology, Biotechnology Research, Health Care, Health Diagnostics, Life Science, Medical, Therapeutics"  
hq: "Horgen, Switzerland"  
founded_year: "2011"  
linkedin: "https://www.linkedin.com/company/numab-ag"  
twitter: "https://twitter.com/numab_tx"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/numab-ag"  
pitchbook: ""  

date_display: "10-Jan-2025"  
date: "2025-01-10"

# SEO Optimization  
meta_title: "Numab Therapeutics - Series C Funding ($55M)"  
meta_description: "Numab Therapeutics, Numab Therapeutics is a clinical-stage biotech company developing multi-specific antibody-based immunotherapies for inflammation and cancer. They util..."  
meta_keywords: "Numab Therapeutics, Biotech, Oncology, Immunology, Biotechnology Research, Health Care, Health Diagnostics, Life Science, Medical, Therapeutics, Series C funding"  
canonical_url: "https://startup.projectstartups.com/numabtherapeuticsnumab.com01102025/"  
---